Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21+0.06 (+5.22%)
Close on Nov 17, 2026Market cap $76.72MP/E –Yield –
Equillium operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Equillium's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.97M. For fiscal 2025 it was -$22.75M. The highest annual figure on record is -$7.53M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.75M | – |
| FY2024 | Dec 31, 2024 | -$19.03M | – |
| FY2023 | Dec 31, 2023 | -$21.78M | – |
| FY2022 | Dec 31, 2022 | -$8.73M | – |
| FY2021 | Dec 31, 2021 | -$32.08M | – |
| FY2020 | Dec 31, 2020 | -$24.62M | – |
| FY2019 | Dec 31, 2019 | -$22.95M | – |
| FY2018 | Dec 31, 2018 | -$7.53M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.11M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.30M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.13M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.01M | -512.7% |
| Q1 FY2025 | Mar 31, 2025 | -$8.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.66M | – |
| Q2 FY2024 | Jun 30, 2024 | $730.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.80M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.66M | -120.4% |
| Q3 FY2023 | Sep 30, 2023 | -$1.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $27.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.26M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.13M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.01M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.99M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.94M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.25M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.37M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.03M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.76M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.46M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.83M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.17M | – |
| Q1 FY2018 | Mar 31, 2018 | -$889.00K | – |
See a number that looks wrong?